Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | ABL1 | P00519 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.44 |
| ▸ | DNM2 | P50570 | 3/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28700733 | 0.97 | ABL1 (0.55) | ADRA2AABL1GPR84ALDH1A1TSHR | |
| SCHEMBL18386504 | 0.89 | ADRA2A (0.50) | ADRA2AABL1GPR84ALDH1A1DNM2 | |
| SCHEMBL8958338 | 0.86 | THRB (0.52) | ADRA2AABL1GPR84ALDH1A1KCNH3 | |
| SCHEMBL3662823 | 0.86 | ABL1 (0.54) | ADRA2AABL1ALDH1A1KCNH3EPHX1 | |
| SCHEMBL6233796 | 0.86 | KCNH3 (0.47) | ADRA2AABL1GPR84ALDH1A1TSHR | |
| SCHEMBL10381587 | 0.84 | ADRA2A (0.50) | ADRA2AABL1GPR84ALDH1A1DNM2 | |
| SCHEMBL7998280 | 0.84 | ADRA2A (0.50) | ADRA2AABL1GPR84ALDH1A1DNM2 | |
| SCHEMBL9187399 | 0.84 | GPR84 (0.51) | ADRA2AABL1GPR84KCNH3 | |
| SCHEMBL5605010 | 0.84 | ADRA2A (0.50) | ADRA2AABL1GPR84ALDH1A1DNM2 | |
| SCHEMBL27893435 | 0.84 | ADRA2A (0.50) | ADRA2AABL1GPR84ALDH1A1DNM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | claimed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | claimed |
| US-7196224-B2 | 1,3,5-tris(arylamino)benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-27 | — | — | US | claimed |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-03 | — | — | US | claimed |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-28 | — | — | US | claimed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | claimed |
| CN-117865838-A | Preparation method of N, N ', N ' ' -tripentyl-1, 3, 5-triaminobenzene | 中国融通资源开发集团有限公司 | 2024-04-12 | — | — | CN | disclosed |
| JP-2010280635-A | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENES AND USE THEREOF | BANDO CHEM IND LTD | 2010-12-16 | — | — | JP | disclosed |
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | disclosed |
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | disclosed |
| CN-100402489-C | Novel 1,3, 5-tris (arylamino) benzenes | BANDO CHEMICAL IND (JP) | 2008-07-16 | — | — | CN | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | disclosed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | disclosed |
| JP-2004277385-A | NEW 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEM IND LTD | 2004-10-07 | — | — | JP | disclosed |
| WO-2004083161-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2004-09-30 | — | — | WO | disclosed |
| JP-2004155754-A | NEW 1,3,5-TRIS(ARYLAMINO)BENZENE COMPOUND | BANDO CHEM IND LTD | 2004-06-03 | — | — | JP | disclosed |
| WO-2003080558-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | HSPA4L, HSPA1A, GAPVD1 | ADRA2A 1361/4885ABL1 498/4885GPR84 4163/4885 |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | AHR, MYB, NAP1L4 | ADRA2A 1196/4885ABL1 294/4885GPR84 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.